- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Human immunodeficiency virus (HIV)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 313KB)
Lenacapavir – November 2023
Lenacapavir: Injection set containing 2 vials lenacapavir sodium solution for injection 463.5 mg in 1.5 mL and 2 disposable syringes; Sunlenca®
Last updated
1 March 2024